EWTX Edgewise Therapeutics, Inc.
$35.58
▼ 3.81%
38
Value
29
P/E-21.65
8
P/B7.73
43
P/S0.00
70
EV/EBITDA-20.13
5
Growth
37
Revenue Growth0.0%
28
EPS Growth-12.4%
42
FCF Growth-30.3%
41
Momentum
82
12-Month Return147.4%
100
3-Month Return30.9%
100
1-Month Return7.7%
67
RSI (14)53.58
57
50/200 MABullish
75
Profitability
19
ROE-32.5%
45
ROA-33.9%
0
Gross Margin0.0%
14
Operating Margin0.0%
21
Net Margin0.0%
26
FCF Yield-3.9%
0
Risk
16
Beta0.25
35
60-Day Volatility55.2%
0
QScore Analysis